Skip to main content

Market Overview

Sterne Agee Sees 16% Upside for Actavis, Initiates Coverage

Share:

Shares of Actavis (NYSE: ACT) are up 2.3 percent to $198.42 in Wednesday's trading after Sterne Agee initiated coverage on the stock with a Buy rating and $230 price target.

Analyst Shibani Malhotra sees upside “to the company's pro-revenue and synergy targets, and expects management to continue to implement on its disciplined inorganic growth strategy.”

The analyst is also bullish on the company's growth profile following its recent merger with Forest Laboratories.

Latest Ratings for ACT

DateFirmActionFromTo
Oct 2021CitigroupInitiates Coverage OnBuy
Oct 2021JP MorganInitiates Coverage OnOverweight
Oct 2021Credit SuisseInitiates Coverage OnNeutral

View More Analyst Ratings for ACT

View the Latest Analyst Ratings

 

Related Articles (ACT)

View Comments and Join the Discussion!

Posted-In: forest laboratories Shibani Malhotra Sterne AgeeAnalyst Color Initiation Analyst Ratings

Latest Ratings

StockFirmActionPT
SEDGB of A SecuritiesMaintains411.0
PTLOPiper SandlerMaintains28.0
AOUTLake StreetMaintains26.0
RAPTPiper SandlerMaintains52.0
OCXLake StreetMaintains6.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com